Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LOX | P28300 | 1/20 | 0.71 |
| ▸ | LOXL3 | P58215 | 1/20 | 0.71 |
| ▸ | LOXL4 | Q96JB6 | 1/20 | 0.71 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.71 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.67 |
| ▸ | GFER | P55789 | 1/20 | 0.67 |
| ▸ | CES2 | O00748 | 4/20 | 0.61 |
| ▸ | LMNA | P02545 | 3/20 | 0.59 |
| ▸ | HTT | P42858 | 2/20 | 0.59 |
| ▸ | PKM | P14618 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 9/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.58 |
| ▸ | NPC1 | O15118 | 2/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.58 |
| ▸ | RAB9A | P51151 | 1/20 | 0.58 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.51 |
| ▸ | MEN1 | O00255 | 7/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL190373 | 0.89 | LOX (0.58) | LOXLOXL3LOXL4LOXL2ALDH1A1 | |
| SCHEMBL8992445 | 0.86 | LOX (0.55) | LOXLOXL3LOXL4LOXL2ALDH1A1 | |
| SCHEMBL11051305 | 0.84 | LOX (0.52) | LOXLOXL3LOXL4LOXL2ALDH1A1 | |
| SCHEMBL1086022 | 0.83 | LOX (1.00) | LOXLOXL3LOXL4LOXL2ALDH1A1 | |
| SCHEMBL12766787 | 0.81 | LOX (0.67) | LOXLOXL3LOXL4LOXL2ALDH1A1 | |
| SCHEMBL6262518 | 0.81 | ALDH1A1 (0.68) | LOXLOXL3LOXL4LOXL2ALDH1A1 | |
| SCHEMBL13292395 | 0.80 | LOX (0.70) | LOXLOXL3LOXL4LOXL2ALDH1A1 | |
| SCHEMBL30641875 | 0.80 | ALDH1A1 (1.00) | LOXLOXL3LOXL4LOXL2ALDH1A1 | |
| SCHEMBL12083825 | 0.80 | LOX (0.51) | LOXLOXL3LOXL4LOXL2ALDH1A1 | |
| SCHEMBL21103310 | 0.79 | LOX (0.63) | LOXLOXL3LOXL4LOXL2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 211 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12024648-B2 | Graphene anti-corrosion coating | TORAY INDUSTRIES, INC. (JP) | 2024-07-02 | — | — | US | claimed |
| CN-113039251-B | Graphene anticorrosive paint | 东丽先端材料研究开发（中国）有限公司 | 2022-09-09 | — | — | CN | claimed |
| US-20210395536-A1 | GRAPHENE ANTI-CORROSION COATING | TORAY INDUSTRIES, INC. (JP) | 2021-12-23 | — | — | US | claimed |
| EP-3889224-A1 | GRAPHENE ANTI-CORROSION COATING | Toray Industries, Inc. (JP) | 2021-10-06 | — | — | EP | claimed |
| CN-113039251-A | Graphene anticorrosive paint | 东丽先端材料研究开发（中国）有限公司 | 2021-06-25 | — | — | CN | claimed |
| US-10092786-B2 | Fire extinguishing composition comprising aldoketones compound | XI'AN WESTPEACE FIRE TECHNOLOGY CO., LTD. (CN) | 2018-10-09 | — | — | US | claimed |
| US-20160332016-A1 | Fire Extinguishing Composition Comprising Aldoketones Compound | NANO FIRE, LLC | 2016-11-17 | — | — | US | claimed |
| JP-52051366-A | — | — | None | — | — | JP | disclosed |
| EP-3604581-B1 | BLACK HEART MALLEABLE CAST-IRON AND METHOD FOR MANUFACTURING SAME | KUWANA METALS LTD (JP) | 2026-04-22 | — | — | EP | disclosed |
| US-20260069570-A1 | STABLE PHARMACEUTICAL COMPOSITIONS OF EDARAVONE | SLAYBACK PHARMA LLC (US) | 2026-03-12 | — | — | US | disclosed |
| US-12491178-B2 | Stable pharmaceutical compositions of edaravone | SLAYBACK PHARMA LLC (US) | 2025-12-09 | — | — | US | disclosed |
| US-20250268865-A1 | STABLE PHARMACEUTICAL COMPOSITIONS OF EDARAVONE | SLAYBACK PHARMA LLC (US) | 2025-08-28 | — | — | US | disclosed |
| US-20250235431-A1 | STABLE PHARMACEUTICAL COMPOSITIONS OF EDARAVONE | SLAYBACK PHARMA LLC (US) | 2025-07-24 | — | — | US | disclosed |
| US-4191686-A | FROM SULFONYL HALIDE SUBSTITUTED PARENT BY AMIDATION WITH AROMATIC DIAMINE, DIAZOTIZING, COUPLING TO KETO SUCCINIC ESTER, CYCLIZING, COUPLING TO REACTIVE MOIETY | CASSELLA AKTIENGESELLSCHAFT (DE) | 1980-03-04 | — | — | US | disclosed |
| EP-0001614-A1 | Water-soluble, fibre-reactive, green azo-phthalocyanine dyestuffs, their preparation and their application, as well as the phthalocyanine pyrazolone intermediates and their preparation | CASSELLA Aktiengesellschaft (DE) | 1979-05-02 | — | — | EP | disclosed |
| EP-0001451-A1 | Water-soluble azo-phthalocyanine fibre-reactive dyestuffs, their preparation and their use | CASSELLA Aktiengesellschaft (DE) | 1979-04-18 | — | — | EP | disclosed |
| US-4137080-A | POLYFUNCTIONAL COUPLER AND DEVELOPER | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) | 1979-01-30 | — | — | US | disclosed |
| JP-S5251366-A | PREPARATION OF BISPYRAZOLON DERIVATIVES | OTSUKA CHEM CO LTD | 1977-04-25 | — | — | JP | disclosed |
| US-3935016-A | Silver halide color photographic materials containing 3-anilino-5-pyrazolone couplers | FUJI PHOTO FILM COMPANY, LTD. (JA) | 1976-01-27 | — | — | US | disclosed |
| US-3930866-A | MAGENTA | FUJI PHOTO FILM CO., LTD. (JA) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250235431-A1 | STABLE PHARMACEUTICAL COMPOSITIONS OF EDARAVONE | EDNRA, EDNRB, FASTKD5 | LOX 1557/4885LOXL3 2130/4885LOXL4 3272/4885 |
| US-12491178-B2 | Stable pharmaceutical compositions of edaravone | EDNRA, EDNRB, FASTKD5 | LOX 1557/4885LOXL3 2130/4885LOXL4 3272/4885 |
| US-20250268865-A1 | STABLE PHARMACEUTICAL COMPOSITIONS OF EDARAVONE | EDNRA, EDNRB, FASTKD5 | LOX 1557/4885LOXL3 2130/4885LOXL4 3272/4885 |
| US-20260069570-A1 | STABLE PHARMACEUTICAL COMPOSITIONS OF EDARAVONE | ADH1C, ADH1A, SLC25A11 | LOX 2196/4885LOXL3 3800/4885LOXL4 4231/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.